Oncotarget

May 14, 2019

View Archive »

About The Cover

The cover for issue 35 of Oncotarget features Figure 8A (TOP PANEL), "Hep-2 cells were incubated with the indicated compounds in the presence of HSV1-Luc virus at a concentration of 4 X 106 pfu/ml media," and Figure 2A (BOTTOM PANEL), "Docked Model of RACK1A with SD-29 at the Y248 phosphorylation site," by Ullah, et al.

Table of Contents

Editorial

Obesity: an heavyweight player in breast cancer’s chemoresistance

Obesity: an heavyweight player in breast cancer’s chemoresistance

https://doi.org/10.18632/oncotarget.26905

Charlotte Vaysse, Catherine Muller,  and Frédérique Fallone
3207-3208
PDF  |  How to cite

Research Papers

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation

https://doi.org/10.18632/oncotarget.26907

Hemayet Ullah, Wangheng Hou, Sivanesan Dakshanamurthy,  and Qiyi Tang
3209-3226
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Podcast  |  Video Interview

Deregulated expression of NKL homeobox genes in T-cell lymphomas

Deregulated expression of NKL homeobox genes in T-cell lymphomas

https://doi.org/10.18632/oncotarget.26929

Stefan Nagel, Claudia Pommerenke, Roderick A.F. MacLeod, Corinna Meyer, Maren Kaufmann, Silke Fähnrich,  and Hans G. Drexler
3227-3247
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells

Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells

https://doi.org/10.18632/oncotarget.26933

Olga Gordeeva, Andrey Gordeev,  and Sergey Khaydukov
3248-3266
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research

A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research

https://doi.org/10.18632/oncotarget.26938

Xiaoman Chen, Yulu Shi, Kaiwen Zhou, Sijie Yu, Wei Cai,  and Muying Ying
3267-3275
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X

https://doi.org/10.18632/oncotarget.26852

Reiko Yoshida, Chie Watanabe, Shiro Yokoyama, Mayuko Inuzuka, Junko Yotsumoto, Masami Arai, Seigo Nakamura,  and  the Registration Committee of the Japanese HBOC consortium
3276-3284
Abstract  |  PDF  |  Full Text  |  How to cite

Meta-Analysis

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

https://doi.org/10.18632/oncotarget.26904

Ling Wang, Hung Lam, Yaping Shou,  and Aaron Galaznik
3285-3293
Abstract  |  PDF  |  Full Text  |  How to cite

Reviews

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials

https://doi.org/10.18632/oncotarget.26908

Alberto Carretero-González, David Lora, Ismael Ghanem, Irene Otero, Flora López, Daniel Castellano,  and Guillermo de Velasco
3294-3301
Abstract  |  PDF  |  Full Text  |  How to cite

Case Reports

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab

https://doi.org/10.18632/oncotarget.26906

Anna Kathrin Stüven,  and Bertram Wiedenmann
3302-3311
Abstract  |  PDF  |  Full Text  |  How to cite

Corrections

Correction: A keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer

Correction: A keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer

https://doi.org/10.18632/oncotarget.26962

Michael R. Evans, Claire D. James, Oonagh Loughran, Tara J. Nulton, Xu Wang, Molly L. Bristol, Brad Windle,  and Iain M. Morgan
3312-3312
Correction  |  PDF  |  How to cite

Correction: Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease

Correction: Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease

https://doi.org/10.18632/oncotarget.26963

Lei Peng, Guanglin Chen, Zhongxian Zhu, Ziyang Shen, Chunxia Du, Rujin Zang, Yang Su, Hua Xie, Hongxing Li, Xiaoqun Xu, Yankai Xia,  and Weibing Tang
3313-3314
Correction  |  PDF  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC